Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Endomucin marks quiescent long-term multi-lineage repopulating hematopoietic stem cells and is essential for their transendothelial migration.

Sophia Engelhard | Montserrat Estruch | Shuyu Qin | Christoph A Engelhard | Francisco G Rodriguez-Gonzalez | Martine Drilsvik | Javier Martin-Gonzalez | Jeng-Wei Lu | David Bryder | Claus Nerlov | Joachim Weischenfeldt | Kristian Reckzeh | Kim Theilgaard-Mönch
Cell reports | 2024

Endomucin (EMCN) currently represents the only hematopoietic stem cell (HSC) marker expressed by both murine and human HSCs. Here, we report that EMCN+ long-term repopulating HSCs (LT-HSCs; CD150+CD48-LSK) have a higher long-term multi-lineage repopulating capacity compared to EMCN- LT-HSCs. Cell cycle analyses and transcriptional profiling demonstrated that EMCN+ LT-HSCs were more quiescent compared to EMCN- LT-HSCs. Emcn-/- and Emcn+/+ mice displayed comparable steady-state hematopoiesis, as well as frequencies, transcriptional programs, and long-term multi-lineage repopulating capacity of their LT-HSCs. Complementary functional analyses further revealed increased cell cycle entry upon treatment with 5-fluorouracil and reduced granulocyte colony-stimulating factor (GCSF) mobilization of Emcn-/- LT-HSCs, demonstrating that EMCN expression by LT-HSCs associates with quiescence in response to hematopoietic stress and is indispensable for effective LT-HSC mobilization. Transplantation of wild-type bone marrow cells into Emcn-/- or Emcn+/+ recipients demonstrated that EMCN is essential for endothelial cell-dependent maintenance/self-renewal of the LT-HSC pool and sustained blood cell production post-transplant.

Pubmed ID: 38996072

Research resources used in this publication

Additional research tools detected in this publication

None found

Antibodies used in this publication

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


CD135 (FLT3) (antibody)

RRID:AB_2737639

This monoclonal targets CD135 (FLT3)

View all literature mentions

FITC anti-mouse CD45.1 (antibody)

RRID:AB_313495

This monoclonal targets CD45.1

View all literature mentions

FITC anti-mouse CD45.2 (antibody)

RRID:AB_313443

This monoclonal targets CD45.2

View all literature mentions

Ig (antibody)

RRID:AB_393876

This polyclonal targets Ig

View all literature mentions

PE/Cyanine7 anti-mouse CD48 (antibody)

RRID:AB_2075049

This monoclonal targets CD48

View all literature mentions

APC anti-mouse CD45.1 (antibody)

RRID:AB_313503

This monoclonal targets CD45.1

View all literature mentions

PE anti-mouse CD3epsilon (antibody)

RRID:AB_312673

This monoclonal targets CD3epsilon

View all literature mentions

C57BL/6NTac (organism)

RRID:IMSR_TAC:B6

Mus musculus with name C57BL/6NTac from IMSR.

View all literature mentions